NORTHERN TRUST CORP - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 82 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,243,774
-10.2%
723,124
+1.8%
0.00%
Q2 2023$1,385,473
+226.7%
710,499
+365.7%
0.00%
Q1 2023$424,117
-17.3%
152,560
+2.6%
0.00%
Q4 2022$512,912
+61.8%
148,670
+20.6%
0.00%
Q3 2022$317,000
+13.6%
123,320
+7.0%
0.00%
Q2 2022$279,000
-82.9%
115,280
-70.9%
0.00%
Q1 2022$1,633,000
-68.9%
396,347
-3.1%
0.00%
-100.0%
Q4 2021$5,259,000
+31.8%
408,906
+10.7%
0.00%0.0%
Q3 2021$3,990,000
-13.4%
369,403
-26.8%
0.00%0.0%
Q2 2021$4,606,000
+72.8%
504,435
+78.5%
0.00%
Q1 2021$2,666,000
+126.3%
282,646
-5.5%
0.00%
Q4 2020$1,178,000
+40.1%
298,953
-5.8%
0.00%
Q3 2020$841,000
-62.6%
317,313
-6.3%
0.00%
-100.0%
Q2 2020$2,248,000
+33.3%
338,503
+16.8%
0.00%
Q1 2020$1,687,000
-32.7%
289,853
+3.7%
0.00%
-100.0%
Q4 2019$2,508,000
+7.5%
279,591
+3.5%
0.00%0.0%
Q3 2019$2,333,000
+81.4%
270,164
+134.1%
0.00%
Q2 2019$1,286,000
+23.5%
115,395
+47.4%
0.00%
Q1 2019$1,041,000
-13.8%
78,276
+0.2%
0.00%
Q4 2018$1,207,00078,1070.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders